Chronic Respiratory Disease Participant Engagement Study
NCT07924462, Recruiting, Richmond Research Institute
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Chronic Respiratory Disease Participant Engagement Study | ClinicalTrials.gov |
| NCT number | NCT07924462 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Enrollment | 500 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Richmond Research Institute | ClinicalTrials.gov |
| Conditions | Interstitial Lung Disease (ILD), Chronic Respiratory Diseases, Alpha-1 Antitrypsin Deficiency (AATD), Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Number of patients indicating willingness to be re-contacted for future clinical trials | Until the end of the study (up to 5 weeks)] | ClinicalTrials.gov | |
| Primary | Participation feedback questionnaire results using Participant Feedback and Clinical Research Experience Questionnaire | Until the end of the study (up to 5 weeks)] | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of medical history | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of exacerbation history | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of smoking status | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of concomitant medications (con-meds) | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of respiratory rate | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of body temperature | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of pulse rate | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of oxygen saturation | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of blood pressure | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of Lung function for FEV1 parameter | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of Lung function for FVC parameter | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of Lung function for FEV1/FVC ratio | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of oxygen use | Day 1 | ClinicalTrials.gov | |
| Secondary | Clinical baseline characterisation of bloods including genetic testing where clinically indicated and imaging data where available. | Day 1 | ClinicalTrials.gov | |
| Secondary | Number and proportion of new diagnoses following assessment | Until the end of the study (up to 5 weeks)] | ClinicalTrials.gov | |
| Secondary | Factors associated with underdiagnosis by exploring differences between patient-reported outcomes and clinical data, including potential variations by age, sex and ethnicity | Until the end of the study (up to 5 weeks)] | ClinicalTrials.gov | |
| Secondary | Differences in patient-reported outcome scores between chronic respiratory disease subgroups using EQ-5D-5L together with the EQ Visual Analogue Scale (EQ VAS) | Until the end of the study (up to 5 weeks)] | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)